Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Idiopathic pulmonary fibrosis: Current and future treatment
Daniel S. Glass, David Grossfeld, Heather A. Renna, et al.
The Clinical Respiratory Journal (2022) Vol. 16, Iss. 2, pp. 84-96
Open Access | Times Cited: 194

Showing 1-25 of 194 citing articles:

Recent advances in nanoparticle applications in respiratory disorders: a review
Mohammad Ehsan Taghavizadeh Yazdi, Mohsen Qayoomian, Sima Beigoli, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 42
Mitochondria‐Targeted Nanoadjuvants Induced Multi‐Functional Immune‐Microenvironment Remodeling to Sensitize Tumor Radio‐Immunotherapy
Zaigang Zhou, Cheng Li, Chao Li, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Open Access | Times Cited: 17
Early Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis: A Narrative Review
H Alsomali, Evelyn Palmer, Avinash Aujayeb, et al.
Pulmonary Therapy (2023) Vol. 9, Iss. 2, pp. 177-193
Open Access | Times Cited: 25
Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues
Panoraia I. Siafaka, Ece Özcan Bülbül, Αndroulla N. Miliotou, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105381-105381
Closed Access | Times Cited: 9
Recent advances in intestinal fibrosis
Marco Vincenzo Lenti, Giovanni Santacroce, Giacomo Broglio, et al.
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101251-101251
Closed Access | Times Cited: 8
Physical Exercise: A Promising Treatment Against Organ Fibrosis
Xiaojie Ma, Bing Liu, Ziming Jiang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 343-343
Open Access | Times Cited: 1
Phillygenin Inhibits PI3K‐Akt–mTOR Signalling Pathway to Prevent bleomycin‐Induced Idiopathic Pulmonary Fibrosis in Mice
Yongjia Wei, Wenting Ni, Lizhi Zhao, et al.
Clinical and Experimental Pharmacology and Physiology (2025) Vol. 52, Iss. 2
Closed Access | Times Cited: 1
Deciphering the cellular and molecular landscape of pulmonary fibrosis through single-cell sequencing and machine learning
Yong Zhou, Zhongkai Tong, Xiaoxiao Zhu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Health position paper and redox perspectives – Bench to Bedside Transition for Pharmacological Regulation of NRF2 in Noncommunicable Diseases
Antonio Cuadrado, Eduardo Cazalla, Anders Bach, et al.
Redox Biology (2025), pp. 103569-103569
Open Access | Times Cited: 1
The use of mechanical ventilation in interstitial lung disease
T. Nolan, Isabel Dwyer, Pierce Geoghegan
Breathe (2025) Vol. 21, Iss. 2, pp. 240172-240172
Open Access | Times Cited: 1
Advances in the Use of N-Acetylcysteine in Chronic Respiratory Diseases
Daniela Mokrá, Juraj Mokrý, Romana Barošová, et al.
Antioxidants (2023) Vol. 12, Iss. 9, pp. 1713-1713
Open Access | Times Cited: 22
Macrophage Implication in IPF: Updates on Immune, Epigenetic, and Metabolic Pathways
Deepak Pokhreal, Bruno Crestani, Doumet Georges Helou
Cells (2023) Vol. 12, Iss. 17, pp. 2193-2193
Open Access | Times Cited: 19
Aerosol pulmonary immune engineering
Emma R. Sudduth, Michael Trautmann-Rodriguez, Nicole Gill, et al.
Advanced Drug Delivery Reviews (2023) Vol. 199, pp. 114831-114831
Open Access | Times Cited: 18
Metabolism-driven glycosylation represents therapeutic opportunities in interstitial lung diseases
Katarzyna Drzewicka, Zbigniew Zasłona
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
The Role of Lung Microbiome in Fibrotic Interstitial Lung Disease—A Systematic Review
Ruxandra Puiu, Nicoleta Ștefania Motoc, Sergiu Lucaciu, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 247-247
Open Access | Times Cited: 6
Exploring Extracellular Matrix Crosslinking as a Therapeutic Approach to Fibrosis
S. Lloyd, Yupeng He
Cells (2024) Vol. 13, Iss. 5, pp. 438-438
Open Access | Times Cited: 6
Involvement of E3 ubiquitin ligase NEDD4-mediated YY1 ubiquitination in alleviating idiopathic pulmonary fibrosis
Lin Chen, Qingxiang Sun, Ruiming Yue, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131976-131976
Closed Access | Times Cited: 6
Roles of exosomes and exosome-derived miRNAs in pulmonary fibrosis
Yongfeng Yang, Hong Huang, Yi Li
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Tacrolimus ameliorates bleomycin-induced pulmonary fibrosis by inhibiting M2 macrophage polarization via JAK2/STAT3 signaling
Bowen Liu, Qiuyan Jiang, Ruxuan Chen, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109424-109424
Open Access | Times Cited: 23
Mesenchymal cells in the Lung: Evolving concepts and their role in fibrosis
Giovanni Ligresti, Ahmed Raslan, Jeongmin Hong, et al.
Gene (2023) Vol. 859, pp. 147142-147142
Open Access | Times Cited: 15
Menstrual blood-derived stem cells exosomal miR-let-7 to ameliorate pulmonary fibrosis through inhibiting ferroptosis by Sp3/HDAC2/Nrf2 signaling pathway
Lifang Sun, Xinxin He, Jiao Kong, et al.
International Immunopharmacology (2023) Vol. 126, pp. 111316-111316
Closed Access | Times Cited: 15
Macrophage polarization in tissue fibrosis
Huidan Yang, Hao Cheng, Rongrong Dai, et al.
PeerJ (2023) Vol. 11, pp. e16092-e16092
Open Access | Times Cited: 14
Quercetin influences intestinal dysbacteriosis and delays alveolar epithelial cell senescence by regulating PTEN/PI3K/AKT signaling in pulmonary fibrosis
Wenjuan Wu, Xinhui Wu, Lingxiao Qiu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 7, pp. 4809-4822
Open Access | Times Cited: 13
Idiopathic Pulmonary Fibrosis: Where do We Stand and How Far to Go?
Vaishali Singh, Ilya V. Ulasov, Sachin Gupta, et al.
Discovery Medicine (2024) Vol. 36, Iss. 180, pp. 22-22
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top